2022 / 05

Next Paper
DOI: 10.24075/brsmu.2022.055

ORIGINAL RESEARCH

Frequent association of vitiligo with autoimmune endocrine diseases: primary data of the Russian cohort of adult patients

Nuralieva NF1, Yukina MYu1, Troshina EA1, Zhukova OV2,3, Petrov VA2, Volnukhin VA2
About authors

1 Endocrinology Research Centre, Moscow, Russia

2 Moscow Scientific and Practical Center of Dermatovenereology and Cosmetology, Moscow, Russia

3 Peoples’ Friendship University of Russia, Moscow, Russia

Correspondence should be addressed: Nurana F. Nuralieva
Dmitriya Ulyanova, 11, Moscow, 117292, Russia; ur.xednay@anarunn

About paper

Funding: this work was supported by Foundation for Scientific and Technological Development of Yugra (agreement No 2022-05-01/2022).

Author contribution: Nuralieva NF — endocrinology examination, data acquisition, statistical analysis, literature analysis, manuscript writing, preparation of the article for publication; Yukina MYu — study concept development, endocrinology examination, manuscript editing; Troshina EA — approval of the study concept and the final text of the manuscript; Zhukova OV — approval of the final text of the manuscript; Petrov VA — dermatology examination, data acquisition, literature analysis; Volnukhin VA — approval of the study concept, dermatology examination, manuscript editing and approval of the final text.

Compliance with ethical standards: the study was approved by the Ethics Commitee of the Endocrinology Research Centre (protocol № 17 of 27 September 2017); the informed consent was submitted by all patients.

Received: 2022-09-29 Accepted: 2022-10-13 Published online: 2022-10-29
|
Figure. The prevalence of autoimmune endocrine disorders in the cohort of adult patient with vitiligo initially monitored in the Endocrinology Research Centre
Table 1. Characteristics of study participants
Note: М — male, F — female.
Table 2. The prevalence of AEDs and the AITDs and pancreatic islet autoimmunity marker antibodies positivity in female and male vitiligo patients initially monitored in the Endocrinology Research Centre
Note: М — male, F — female.
Table 3. The prevalence of AEDs and antibodies positivity in female and male vitiligo patients initially monitored in the Moscow Scientific and Practical Center of Dermatovenereology and Cosmetology
Note: М — male, F — female.